Received: 23 April 2020
Accepted: 24 July 2020
First Online: 10 August 2020
Ethics approval and consent to participate
: This retrospective, clinical review was approved by the Mayo Clinic Florida Institutional Review Board (ID: 18–006620). It was approved by expedited review procedures (45 CFR 46.110, item 5). The Reviewer conducted a risk-benefit analysis, and determined the study constitutes minimal risk research.
: Not applicable.
: The authors declare that they have no competing interests.